Mv Capital Management, Inc. Neurocrine Biosciences Inc Transaction History
Mv Capital Management, Inc.
- $892 Million
- Q4 2024
A detailed history of Mv Capital Management, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mv Capital Management, Inc. holds 16 shares of NBIX stock, worth $1,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 10
60.0%
Holding current value
$1,790
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.13 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$547 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$338 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$284 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...